NoninvestorAB,

We all know the answer to that. Multi billion dollar companies controlled the diagnostics market with their PCR technologies and it wasn’t possible to crack that hold. Now PCR has shown its cracks with glaring errors in CoVid19 detection that may open the door to alternative technologies. Hopefully that door will be large enough for their N-Assay to fit alongside their viral assay.

Scott.